MRAI · Marpai, Inc.
$0.65
At close · May 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that our liquidity condition raises substantial doubt about our ability to continue as a going concern through twelve months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$62.51M
Shares
26.83M
Volume · May 29
227.3K
Avg daily vol (3M)
419.62K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.65
Open$0.55
Day$0.40–0.90
52W close$0.37–2.92
Avg vol 30d126K
Short int90K · 0.3% float · 1.0d
Short vol62%
Last earningsNov 13, 2025
DataOct 2021–May 2024
Filing10-Q · Aug 13
Up next
filed Aug 13, 2026
call held Nov 13, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$16.64M
Trailing 12 months
Net income (TTM)
−$16.89M
Trailing 12 months
Revenue growth YoY
-10.5%
Year over year
Operating margin
-81.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$20.59M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+66.8%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−55%
below
Price vs 50-day avg
−70%
below
RSI (14)
20
oversold
MACD trend
Negative
52-week position
11%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−68%
trailing
6-month return
−68%
trailing
YTD return
−63%
this year
Relative strength
−83%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.33% of float · ▲ +92.2% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
−36%
Y/Y
EPS growth
+51%
Y/Y
Free cash flow
$-7.8M
Balance sheet
$19.3M
net debt
Quant / Vol
risk profile
Volatility
191%
annualized · 1-yr
Max drawdown
−87%
past year
ATR
44.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guided vs delivered
· last 6 settled
Annual revenues
2023
guided $35M – $36M
$37.16M
Beat +4.7%
Revenue
Q2 2023
guided $9.5M – $9.8M
$10.05M
Beat +4.1%
Revenues
first quarter 2023
guided $9M – $9.3M
$9.67M
Beat +5.7%
Revenue
second quarter 2022
guided $5.2M – $5.5M
$5.56M
Beat +3.9%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−55%
Bearish
Price vs 50-day avg
−70%
Bearish
RSI (14)
20
Neutral
MACD trend
Negative
Bearish
52-week position
11%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.33% of float · ▲ +92.2% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $1 · 11%
Range high $3
vs 200-day avg -55%
vs 50-day avg -70%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MRAI
this stock
Marpai, Inc.
|
$62.51M | — | -35.8% | — | 0.3% |
|
UNH
Unitedhealth Group Inc
|
$372.83B | +23.3% | +11.8% | — | 1.8% |
|
CVS
CVS HEALTH Corp
|
$118.53B | +16.8% | +7.8% | 24.5 | 1.3% |
|
ELV
Elevance Health, Inc.
|
$93.30B | +22.7% | +12.5% | 19.1 | 2.2% |
|
CI
Cigna Group
|
$78.88B | +8.5% | +11.2% | 12.4 | 2.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.1%
- Net QoQ
- +20.5K sh
- Top holder
- FNY Investment Advisers,…
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MRAI | -67.0% | -68.0% | -67.8% | -68.0% | -62.9% |
| SPY | -1.0% | +4.8% | +15.2% | +4.8% | +10.7% |
| vs SPY | -66.0% | -72.8% | -83.0% | -72.8% | -73.6% |